Zervantonakis, Ioannis K <br/><br/>
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.  [electronic resource] 

 -  Nature communications  08 2017 
 - 365 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-017-00263-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Apoptosis<br/>Female<br/>Humans<br/>Myeloid Cell Leukemia Sequence 1 Protein--antagonists & inhibitors<br/>Ovarian Neoplasms--drug therapy<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Systems Biology<br/>TOR Serine-Threonine Kinases--metabolism<br/>X-Linked Inhibitor of Apoptosis Protein--antagonists & inhibitors